propranolol has been researched along with c-peptide in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (76.92) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cryer, PE; Hirsch, IB; Holloszy, JO; Marker, JC; Parvin, CA; Smith, LJ | 1 |
Górski, J; Holm, G; Krotkiewski, M | 1 |
Imanaka, S; Ito, K; Matsuda, S; Matsuoka, T; Okada, Y | 1 |
Bosch, J; Casamitjana, R; Gomis, R; Mastai, R; Navasa, M; Rivera, F; Rodés, J; Silva, G | 1 |
Fyhrquist, F; Groop, L; Groop, PH; Kala, R; Tolppanen, EM; Tötterman, K | 1 |
Hirota, M; Ikegami, H; Kumahara, Y; Shima, K; Tahara, Y; Tanaka, A | 1 |
DeFronzo, RA; Ferrannini, E; Hendler, R; Juhlin-Dannfelt, A; Koivisto, V; Sherwin, RS; Simonson, DC | 1 |
Chan, MK; Ho, PW; Lin, HJ; Pun, KK; Yeung, CK; Yeung, RT | 1 |
Ratzmann, KP; Schulz, B; Witt, S | 1 |
Desjeux, JF; Dieterlen, P; Giraud, M; Lestradet, H; Villard, S | 1 |
Groop, L; Tötterman, KJ | 1 |
Alberti, KG; Kendall-Taylor, P; Trajano, LR; Walker, M | 1 |
Craft, S; Cryer, P; Havlin, CE; Towler, DA | 1 |
2 trial(s) available for propranolol and c-peptide
Article | Year |
---|---|
Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Blood Glucose; C-Peptide; Double-Blind Method; Erythrocytes; Female; Gastric Inhibitory Polypeptide; Humans; Hypertension; Insulin; Islets of Langerhans; Male; Middle Aged; Propranolol; Random Allocation | 1984 |
Propranolol does not inhibit sulphonylurea-stimulated insulin secretion in patients with non-insulin dependent diabetes mellitus.
Topics: Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus; Double-Blind Method; Female; Glipizide; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Propranolol; Random Allocation; Sulfonylurea Compounds; Tolbutamide | 1982 |
11 other study(ies) available for propranolol and c-peptide
Article | Year |
---|---|
Catecholamines in prevention of hypoglycemia during exercise in humans.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Blood Pressure; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Heart Rate; Humans; Hydrocortisone; Hydroxybutyrates; Hypoglycemia; Infusions, Intravenous; Insulin; Kinetics; Male; Phentolamine; Physical Exertion; Propranolol; Reference Values; Somatostatin; Time Factors | 1991 |
Effect of isoproterenol on the plasma C-peptide and insulin levels in humans.
Topics: Adrenergic beta-Agonists; Adult; C-Peptide; Female; Glucose; Humans; Infusions, Intravenous; Insulin; Isoproterenol; Liver; Propranolol; Receptors, Adrenergic, beta; Sympatholytics | 1989 |
Medical treatment for inoperable insulinoma: clinical usefulness of diphenylhydantoin and diltiazem.
Topics: Adenoma, Islet Cell; Aged; Benzazepines; Blood Glucose; C-Peptide; Celiac Artery; Diltiazem; Female; Humans; Insulin; Insulinoma; Pancreatic Neoplasms; Phenytoin; Propranolol; Radiography; Verapamil | 1986 |
Hyperglucagonism and glucagon resistance in cirrhosis. Paradoxical effect of propranolol on plasma glucagon levels.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Drug Resistance; Female; Glucagon; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Propranolol | 1988 |
Effect of three beta-blockers with different pharmacological properties on metabolic, cardiovascular and hormonal response to insulin-induced hypoglycemia in normal subjects.
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Blood Pressure; C-Peptide; Carteolol; Glucagon; Growth Hormone; Hemodynamics; Humans; Hydrocortisone; Hypoglycemia; Insulin; Kinetics; Male; Metoprolol; Propranolol; Pulse | 1984 |
Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Humans; Insulin; Kinetics; Male; Norepinephrine; Phentolamine; Physical Exertion; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Tritium | 1984 |
Effects of propranolol and hemodialysis on the response of glucose, insulin, C-peptide and cyclic AMP to glucagon challenge.
Topics: Adult; Blood Glucose; C-Peptide; Cyclic AMP; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Liver; Male; Middle Aged; Propranolol; Renal Dialysis; Time Factors | 1984 |
Evaluation of insulin resistance in non-obese subjects with impaired glucose tolerance.
Topics: Blood Glucose; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; Glycerol; Humans; Insulin; Insulin Resistance; Kinetics; Male; Propranolol; Reference Values | 1982 |
[Measurement of insulin sensitivity in obese or diabetic children in vivo. A comparison of three methods (author's transl)].
Topics: Adolescent; Blood Glucose; C-Peptide; Child; Diabetes Mellitus; Epinephrine; Glucose; Humans; Insulin; Insulin Resistance; Obesity; Propranolol | 1980 |
Relapse of medically treated insulinoma following the development of thyrotoxicosis: an assessment of potential mechanisms.
Topics: Aged; C-Peptide; Diazoxide; Female; Humans; Hypoglycemia; Insulin; Insulin Resistance; Insulinoma; Pancreatic Neoplasms; Propranolol; Recurrence; Thyrotoxicosis | 1994 |
Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Atropine; Autonomic Nervous System; Awareness; Blood Glucose; Blood Pressure; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Growth Hormone; Heart Rate; Hormones; Humans; Hydrocortisone; Hydroxybutyrates; Hypoglycemia; Insulin; Lactates; Lactic Acid; Male; Norepinephrine; Pancreatic Polypeptide; Phentolamine; Propranolol; Receptors, Adrenergic, beta; Reference Values; Time Factors | 1993 |